Neuropace
NPCE
NPCE
41 hedge funds and large institutions have $182M invested in Neuropace in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
5% more funds holding
Funds holding: 39 → 41 (+2)
2% more capital invested
Capital invested by funds: $177M → $182M (+$4.15M)
Holders
41
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$6.44M | |
| 2 | +$2.61M | |
| 3 | +$1.66M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.37M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$192K |
Top Sellers
| 1 | -$7.05M | |
| 2 | -$1.29M | |
| 3 | -$879K | |
| 4 |
Millennium Management
New York
|
-$875K |
| 5 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$238K |